Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range

Metformin is considered the first-line treatment for type 2 diabetes. While metformin primarily increases insulin sensitivity, evidence also suggests that metformin affects the activity of insulin-secreting pancreatic islets. This study was designed to systematically examine the direct effects of me...

Full description

Saved in:
Bibliographic Details
Main Authors: Lindor Gelin, Jiewen Li, Kathryn L. Corbin, Ishrat Jahan, Craig S. Nunemaker
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2018/9163052
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549513476177920
author Lindor Gelin
Jiewen Li
Kathryn L. Corbin
Ishrat Jahan
Craig S. Nunemaker
author_facet Lindor Gelin
Jiewen Li
Kathryn L. Corbin
Ishrat Jahan
Craig S. Nunemaker
author_sort Lindor Gelin
collection DOAJ
description Metformin is considered the first-line treatment for type 2 diabetes. While metformin primarily increases insulin sensitivity, evidence also suggests that metformin affects the activity of insulin-secreting pancreatic islets. This study was designed to systematically examine the direct effects of metformin by measuring insulin secretion and the kinetics of the calcium response to glucose stimulation in isolated mouse islets using varying concentrations (20 μM, 200 μM, and 1 mM) and durations (~1, 2, and 3 days) of metformin exposure. We observed both concentration- and duration-dependent inhibitory effects of metformin. Concentrations as little as 20 μM (nearing circulating therapeutic levels) were sufficient to reduce insulin secretion following 3-day treatment. Concentrations of 200 μM and 1 mM produced more pronounced effects more rapidly. With 1 mM metformin, islets showed severe impairments in calcium handling, inhibition of insulin secretion, and increased cell death. No stimulatory effects of metformin were observed for any experimental endpoint. We conclude that the direct effects of metformin on islets are inhibitory at near-physiological concentrations. Beneficial effects of metformin observed on islets under various stressors may occur by “resting” fatigued cellular processes. However, metformin may have unintended consequences on normally functioning islets within the circulating range that require further evaluation.
format Article
id doaj-art-5738c521c2e14fcb977a5869b49dde2e
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-5738c521c2e14fcb977a5869b49dde2e2025-02-03T06:11:07ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/91630529163052Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating RangeLindor Gelin0Jiewen Li1Kathryn L. Corbin2Ishrat Jahan3Craig S. Nunemaker4Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USADepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USADepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USADepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USADepartment of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, OH, USAMetformin is considered the first-line treatment for type 2 diabetes. While metformin primarily increases insulin sensitivity, evidence also suggests that metformin affects the activity of insulin-secreting pancreatic islets. This study was designed to systematically examine the direct effects of metformin by measuring insulin secretion and the kinetics of the calcium response to glucose stimulation in isolated mouse islets using varying concentrations (20 μM, 200 μM, and 1 mM) and durations (~1, 2, and 3 days) of metformin exposure. We observed both concentration- and duration-dependent inhibitory effects of metformin. Concentrations as little as 20 μM (nearing circulating therapeutic levels) were sufficient to reduce insulin secretion following 3-day treatment. Concentrations of 200 μM and 1 mM produced more pronounced effects more rapidly. With 1 mM metformin, islets showed severe impairments in calcium handling, inhibition of insulin secretion, and increased cell death. No stimulatory effects of metformin were observed for any experimental endpoint. We conclude that the direct effects of metformin on islets are inhibitory at near-physiological concentrations. Beneficial effects of metformin observed on islets under various stressors may occur by “resting” fatigued cellular processes. However, metformin may have unintended consequences on normally functioning islets within the circulating range that require further evaluation.http://dx.doi.org/10.1155/2018/9163052
spellingShingle Lindor Gelin
Jiewen Li
Kathryn L. Corbin
Ishrat Jahan
Craig S. Nunemaker
Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
Journal of Diabetes Research
title Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
title_full Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
title_fullStr Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
title_full_unstemmed Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
title_short Metformin Inhibits Mouse Islet Insulin Secretion and Alters Intracellular Calcium in a Concentration-Dependent and Duration-Dependent Manner near the Circulating Range
title_sort metformin inhibits mouse islet insulin secretion and alters intracellular calcium in a concentration dependent and duration dependent manner near the circulating range
url http://dx.doi.org/10.1155/2018/9163052
work_keys_str_mv AT lindorgelin metformininhibitsmouseisletinsulinsecretionandaltersintracellularcalciuminaconcentrationdependentanddurationdependentmannernearthecirculatingrange
AT jiewenli metformininhibitsmouseisletinsulinsecretionandaltersintracellularcalciuminaconcentrationdependentanddurationdependentmannernearthecirculatingrange
AT kathrynlcorbin metformininhibitsmouseisletinsulinsecretionandaltersintracellularcalciuminaconcentrationdependentanddurationdependentmannernearthecirculatingrange
AT ishratjahan metformininhibitsmouseisletinsulinsecretionandaltersintracellularcalciuminaconcentrationdependentanddurationdependentmannernearthecirculatingrange
AT craigsnunemaker metformininhibitsmouseisletinsulinsecretionandaltersintracellularcalciuminaconcentrationdependentanddurationdependentmannernearthecirculatingrange